3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Melanoma
1
Esophageal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
18
Trastuzumab
7
Docetaxel
7
Paclitaxel
6
Magnetic Resonance Spectroscopy
5
Taxes
4
Drug Therapy
4
Carboplatin
4
Specimen Handling
3
Psychiatric Rehabilitation
3
Polymerase Chain Reaction
3
Nivolumab
3
Injections
3
Fluorouracil
3
Fluorodeoxyglucose F18
3
Cyclophosphamide
3
Cisplatin
3
Capecitabine
3
Biopsy
3
poly ICLC
2
fludarabine
2
durvalumab
2
belinostat
2
atezolizumab
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Lapatinib
2
Irinotecan
2
Interleukin-12
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
High-Intensity Focused Ultrasound Ablation
×
Breast
×
Clear all
NCT04116320
2025-07-14
AM-003
University of Virginia
Phase 1
Terminated
5 enrolled